yuyu pharma inc
(000220:Korea Stock Exchange (Koscom))
yuyu pharma inc (000220) Snapshot
|
Open
8,870
|
Previous Close
8,780
|
|
|
Day High
9,020
|
Day Low
8,730
|
|
|
52 Week High
05/13/13 - 10,300
|
52 Week Low
05/21/12 - 4,755
|
|
|
Market Cap
51.4B
|
Average Volume 10 Days
229.5K
|
|
|
EPS TTM
322.00
|
Shares Outstanding
5.8M
|
|
|
EX-Date
03/28/13
|
P/E TM
27.4x
|
|
|
Dividend
160.00
|
Dividend Yield
1.81%
|
Related News
yuyu pharma inc (000220) Related Businessweek News
No Related Businessweek News Foundyuyu pharma inc (000220) Details
Yuyu Pharma, Inc. engages in the manufacture and sale of pharmaceutical products in South Korea and internationally. Its prescription drugs include circulatory improvement agents, antiplatelet agents, osteoporosis drugs, antiulcerants, bone metabolism ameliorants, gout preparations, antidepressants, antidiabetic agents, antitubercular agents, antihypertensive drugs, angina pectoris drugs, antibiotics, hemorrhoidal, varicose preparations, and topical corticosteroids. The company’s non-prescription drugs comprise Yupan-C hot powder, Gavicon-S tab., and Koreamin-G cap. It also offers health supplements and quasi drugs. Yuyu Pharma, Inc. was founded in 1941 and is based in Seoul, South Korea.
| Recently Viewed | |||
| 000220:KS | 8,820.00 KRW | +40.00 | |
| Company | Last | Change | |
| No competitor information is available for 000220. | |||
| View Industry Companies | |||
Industry Analysis
000220
Industry Average
| Valuation | 000220 | Industry Range |
| Price/Earnings | 27.7x |
|
| Price/Sales | 1.0x |
|
| Price/Book | 0.9x |
|
| Price/Cash Flow | 21.2x |
|
| TEV/Sales | 0.8x |
|
Post a JobJobs
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
- Thornton, CO | IntuitPosted: Apr 29
Sponsored Financial Commentaries
Sponsored Links
To contact YUYU PHARMA INC, please visit www.yuyu.co.kr. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








